Inventor · disambiguated record
Ramesh Kumar Sistla
Also filed as: SISTLA RAMESH · SISTLA RAMESH KUMAR
32 granted patents·7 pending applications·91 citations·filing 2009–2023
96Inventor score
Top patents by PatentIndex Score
39 records- 0196USRE49880E[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Mar 26, 2024·2 cites·20 claims
- 0295US10912766B2[1,2,4]triazolo[1,5-A]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Feb 9, 2021·6 cites·17 claims
- 0394US9790169B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Oct 17, 2017·19 cites·27 claims
- 0491USRE49893E[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Apr 2, 2024·1 cites·17 claims
- 0591US10071079B2[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Sep 11, 2018·6 cites·20 claims
- 0690US12286428B2Tricyclic heteroaryl compounds useful as IRAK4 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Apr 29, 2025·2 cites·12 claims
- 0788US10959986B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Mar 30, 2021·3 cites·42 claims
- 0888US8987311B2Triazolyl-substituted pyridyl compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Mar 24, 2015·14 cites·16 claims
- 0986US10660877B2Pyridyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted May 26, 2020·6 cites·18 claims
- 1086US2023255941A1[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1185US9862715B2Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jan 9, 2018·5 cites·2 claims
- 1282US10399932B2Inhibitors of indoleamine-2,3-dioxygenase for the treatment of cancerBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Sep 3, 2019·3 cites·13 claims
- 1381US9657009B2Heteroaryl substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted May 23, 2017·4 cites·11 claims
- 1480US9546153B2Bicyclic heterocycle substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 17, 2017·5 cites·9 claims
- 1579US10544120B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 28, 2020·2 cites·3 claims
- 1678US10202390B2Heteroaryl substituted aminopyridine compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Feb 12, 2019·3 cites·12 claims
- 1778US9242975B2Heterocyclic-substituted pyridyl compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 26, 2016·4 cites·13 claims
- 1875US11672780B2[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jun 13, 2023·0 cites·13 claims
- 1975US10167254B2IDO inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jan 1, 2019·1 cites·43 claims
- 2071US10246469B2Biaryl kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 2, 2019·1 cites·8 claims
- 2171US9242976B2Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Jan 26, 2016·1 cites·7 claims
- 2268US11739098B2Substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Aug 29, 2023·0 cites·12 claims
- 2366US9273058B2Substituted pyrazolo-piperazines as casein kinase 1 δ/ε inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Mar 1, 2016·1 cites·14 claims
- 2462US8575161B2Benzofurane, benzothiophene, benzothiazol derivatives as FXR modulatorsROCHE DIDIER·Filed 2009·Granted Nov 5, 2013·1 cites·28 claims
- 2560US2024246918A1Compounds and compositions as eif4e inhibitors and the uses thereofRIBOMETRIX INC·Filed 2023·Application pending·0 cites
- 2658US10544133B2Heteroaryl substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jan 28, 2020·0 cites·9 claims
- 2758US10227340B2Thiazolyl- or thiadiazolyl-substituted pyridyl compounds useful as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Mar 12, 2019·0 cites·8 claims
- 2856US8722930B2Protease inhibitorsGOSWAMI RAJEEV·Filed 2010·Granted May 13, 2014·1 cites·11 claims
- 2954US10023562B2Heteroaryl substituted pyridyl compounds useful as kinase modulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Jul 17, 2018·0 cites·11 claims
- 3053US9598423B2Substituted 4,5,6,7-tetrahydropyrazolo[1,5-A]pyrazine derivatives as casein kinase 1 D/E inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Mar 21, 2017·0 cites·13 claims
- 3153US2021163443A1Febrifugine DerivativesBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 3252US2021253593A1Substituted indole compoundsBRISTOL MYERS SQUIBB CO·Filed 2018·Application pending·0 cites
- 3349US12059420B2Inhibitors of indoleamine 2,3-dioxygenase and methods of their useBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Aug 13, 2024·0 cites·6 claims
- 3449US2009275606A1Heterocyclic Compounds as MEK InhibitorsNOVARTIS AG·Filed 2009·Application pending·0 cites
- 3546US12473304B2Heterocyclic PAD4 inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Nov 18, 2025·0 cites·29 claims
- 3645US2014200225A1Protease inhibitorsORION CORP·Filed 2014·Application pending·0 cites
- 3742US10730863B2Bridged bicyclic compounds as farnesoid X receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 4, 2020·0 cites·27 claims
- 3842US2016122358A1Novel substituted pyrazolo-piperazines as casein kinase 1 d/e inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 3935US10618903B2Heteroaryl substituted aminopyridine compoundsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 14, 2020·0 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →